Lin Yang

机构：Tianjin University of Traditional Chinese Medicine, Hainan Normal University, Beijing Normal University, Kunming Medical University, First Affiliated Hospital of Kunming Medical University · ORCID：0000-0001-8954-9494

发表论文 59 篇 · 总被引 740 次 · h-index 15

代表论文

• Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review) (2023 · International Journal of Molecular Medicine · 被引 121)
• MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions (2024 · Archiv der Pharmazie · 被引 49)
• Ononin alleviates DSS‐induced colitis through inhibiting NLRP3 inflammasome via triggering mitophagy (2023 · Immunity Inflammation and Disease · 被引 33)
• Remimazolam versus propofol in combination with esketamine for surgical abortion: A double‐blind randomized controlled trial (2023 · Clinical and Translational Science · 被引 25)
• Support vector machine deep mining of electronic medical records to predict the prognosis of severe acute myocardial infarction (2022 · Frontiers in Physiology · 被引 20)
• Efficacy and feasibility of a 12-week Tai Chi training for the prophylaxis of episodic migraine in Hong Kong Chinese women: A randomized controlled trial (2022 · Frontiers in Public Health · 被引 17)